menu search

SYGGF / Synairgen appoints new CFO as incumbent bows out after nearly 20 years

Synairgen appoints new CFO as incumbent bows out after nearly 20 years
Synairgen PLC (AIM:SNG, OTC:SYGGF) said Joseph Colliver will succeed John Ward as chief financial officer effective November 6. Colliver comes to Synairgen with experience in senior finance and non-executive roles, most recently in life sciences. Read More
Posted: Oct 11 2023, 02:47
Author Name: Proactive Investors
Views: 112236

SYGGF News  

Synairgen appoints new CFO as incumbent bows out after nearly 20 years

By Proactive Investors
October 11, 2023

Synairgen appoints new CFO as incumbent bows out after nearly 20 years

Synairgen PLC (AIM:SNG, OTC:SYGGF) said Joseph Colliver will succeed John Ward as chief financial officer effective November 6. Colliver comes to Sy more_horizontal

Synairgen hires full-time chief medical officer as drug development ramps up

By Proactive Investors
October 3, 2023

Synairgen hires full-time chief medical officer as drug development ramps up

Synairgen PLC (AIM:SNG, OTC:SYGGF) has appointed seasoned pharmaceutical physician and drug developer Dr. Marcin Mankowski as chief medical officer, e more_horizontal


Search within

Pages Search Results: